GlassScriptPhysician profile
Elizabeth A Willmes
NPI 1346819497
$1,806.66
in general payments reported to CMS, 2019-2025
22 companies · $395 in 2025
The $395 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $170 · 2022: $350 · 2023: $484 · 2024: $407 · 2025: $395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,286.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,232.93 | 2021-2025 | Variax, Fixos, Augment Injectable |
| Integra Lifesciences Corporation | $102.43 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Ethicon US, LLC | $78.39 | 2023 | Vicryl |
| Treace Medical Concepts, INC. | $58.14 | 2022 | |
| Corcept Therapeutics | $40.58 | 2022-2023 | Korlym |
| Novartis Pharmaceuticals Corporation | $27.52 | 2023 | |
| Averitas Pharma INC. | $22.35 | 2024 | Qutenza |
| Smith+Nephew, INC. | $21.71 | 2022 | |
| Polynovo North America LLC | $20.94 | 2025 | Novosorb Btm |
| Chiesi USA, INC. | $19.41 | 2024 | Mycapssa |
| Recordati_rare_diseases_inc. | $18.63 | 2022 | |
| Eusa Pharma (US) LLC | $18.63 | 2022 | |
| Si-Bone, INC. | $17.34 | 2024 | |
| Conetic Solutions, INC. | $16.30 | 2025 | |
| Amryt Pharma Holdings LTD | $15.43 | 2023 | Mycapssa |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $15.13 | 2023 | Omnipod |
| Lilly USA, LLC | $14.65 | 2024 | Zepbound |
| Dexcom, INC. | $14.07 | 2022 | |
| Medtronic, INC. | $14.05 | 2023 | Intellis Adaptivestim |
| Orthofix Medical, INC. | $13.61 | 2025 | Accelstim |
| Axsome Therapeutics, INC. | $12.73 | 2022 | |
| Idorsia Pharmaceuticals US INC | $11.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Willmes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.